High-dose cyclophosphamide compared with antithymocyte globulin for treatment of acquired severe aplastic anemia

Experimental Hematology

Volumn 41, Issue 4, 2013, Pages 328-334

  Zhang, Fengkui ^a   Zhang, Li ^a   Jing, Liping ^a   Zhou, Kang ^a   Wang, Huijun ^a   Peng, Guangxin ^a   Li, Yang ^a   Li, Yuan ^a   Li, Jianping ^a   Ye, Lei ^a   Shi, Lihui ^a   Fan, Huihui ^a   Zhao, Xin ^a   Chu, Yulin ^a   Hao, Yushu ^a   Wang, Jianxiang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; MESNA; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALOPECIA; APLASTIC ANEMIA; ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CONTINUOUS INFUSION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG COST; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG MEGADOSE; DRUG TOLERABILITY; EVENT FREE SURVIVAL; FEMALE; FUNGEMIA; HEMORRHAGIC CYSTITIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; LIVER FAILURE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; NAUSEA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SERUM SICKNESS; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ADULT; ALOPECIA; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CYCLOPHOSPHAMIDE; CYCLOSPORINE; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HEALTH CARE COSTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NAUSEA; OUTCOME ASSESSMENT (HEALTH CARE); REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84876017056     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.01.001     Document Type: Article

References (24)

1. Camitta B.M., Thomas E.D., Nathan D.G., et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979, 53:504-514.
2. Young N.S., Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med 1997, 336:1365-1372.
3. Rosenfeld S., Follmann D., Nunez O., Young N.S. Antithymocyte globulin and cyclosporine for severe aplastic anemia: Association between hematologic response and long-term outcome. JAMA 2003, 289:1130-1135.
4. Scheinberg P., Nunez O., Wu C., Young N.S. Treatment of severe aplastic anaemia with combined immunosuppression: Anti-thymocyte globulin, cyclosporin and mycophenolate mofetil. Br J Haematol 2006, 133:606-611.
5. Locasciulli A., Oneto R., Bacigalupo A., et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: A report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007, 92:11-18.
6. Tichelli A., Schrezenmeier H., Socié G., et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: A study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood 2011, 117:4434-4441.
7. Brodsky R.A., Sensenbrenner L.L., Jones R.J. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood 1996, 87:491-494.
8. Brodsky R.A., Sensenbrenner L.L., Smith B.D., et al. Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med 2001, 135:477-483.
9. Brodsky R.A., Chen A.R., Dorr D., et al. High-dose cyclophosphamide for severe aplastic anemia: Long-term follow-up. Blood 2010, 115:2136-2141.
10. Tisdale J.F., Dunn D.E., Geller N., et al. High-dose cyclophosphamide in severe aplastic anaemia: A randomised trial. Lancet 2000, 356:1554-1559.
11. Tisdale J.F., Maciejewski J.P., Nuñez O., Rosenfeld S.J., Young N.S. Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): Follow-up of a randomized trial. Blood 2002, 100:4668-4670.
12. International Agranulocytosis and Aplastic Anaemia Study Incidence of aplastic anaemia: Relevance of diagnosis criteria. Blood 1987, 70:1718-1721.
13. Camitta B.M., Rappeport J.M., Parkman R., Nathan D.G. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood 1975, 45:355-363.
14. Bacigalupo A., Hows J.M., Gluckman E., et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): A report of the EBMT SAA Working Party. Br J Haematol 1988, 70:177-182.
15. Thomas E.D., Storb R., Fefer A., et al. Aplastic anaemia treated by marrow transplantation. Lancet 1972, 1:284-289.
16. Mathe' G., Schwarzenberg L. Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin - long-term results. Transplant Proc 1976, 8:595-602.
17. Speck B., Cornu P., Jeannet M., et al. Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol 1976, 4:131-137.
18. Sensenbrenner L.L., Steele A.A., Santos G.W. Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies. Exp Hematol 1977, 5:51-58.
19. Territo M.C. Autologous bone marrow repopulation following high dose cyclophosphamide and allogeneic marrow transplantation in aplastic anaemia. Br J Haematol 1977, 36:305-312.
20. Marsh J.C., Ball S.E., Cavenagh J., et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 2009, 147:43-70.
21. Young N.S., Calado R.T., Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006, 108:2509-2519.
22. Bacigalupo A. Aplastic anemia: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2007, 23-28. Review.
23. Jones R.J., Barber J.P., Vala M.S., et al. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995, 85:2742-2746.
24. Kastan M.B., Schlaffer E., Russo J.E., et al. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 1990, 75:1947-1950.